Andrea Christopher
Head of Corporate Communications and Investor Relations, Arenaforms Instituticals
Replay available
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q3 2024 earnings conference call, held 2024-11-07. Replay captured from the company's public earnings webcast.

Head of Corporate Communications and Investor Relations, Arenaforms Instituticals
President and Chief Executive Officer, ARINIA
Chief Financial Officer
Chief Medical Officer
Analyst, TD Cohen
Analyst, Jefferies
Analyst, Lyrinc Partners
Watch the replay and follow the connected company analysis, news, and investor updates for Aurinia Pharmaceuticals Inc.
WEBVTT 00:00:00.438 -- 00:00:05.922 Greetings and welcome to Arena Pharmaceutical's third quarter 2024 earnings call. 00:00:05.922 -- 00:00:09.966 At this time, all participants are in listen-only mode. 00:00:09.966 -- 00:00:14.027 A question and answer session will follow the formal presentation. 00:00:14.049 -- 00:00:18.753 If anyone should require appropriate assistance during the conference, please press star 00:00:18.753 -- 00:00:22.696 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:22.696 -- 00:00:24.197 I 00:00:24.197 -- 00:00:27.748 would now like to turn the conference over to your host, Andrea Christopher, head of 00:00:27.748 -- 00:00:31.329 Corporate Communications and Investor Relations for Arenaforms Instituticals. 00:00:31.329 -- 00:00:34.109 Thank you. You may now begin. 00:00:41.191 -- 00:00:45.291 Thank you, Operator, and thank you to everyone for joining today's call and webcast. 00:00:45.291 -- 00:00:48.672 Joining me on the call this morning are Peter Greenleaf, Arena's President and Chief 00:00:48.672 -- 00:00:52.293 Executive Officer, Joe Miller, our Chief Financial Officer, and Dr. 00:00:52.293 -- 00:00:57.568 Greg Keenan, our Chief Medical Officer. Today, we will review and discuss ARINIA's 2024 00:00:57.568 -- 00:01:01.729 third quarter financial and operational results, as communicated in the company's press 00:01:01.729 -- 00:01:06.611 release issued this morning. The company also filed its quarterly financial statements 00:01:06.611 -- 00:01:11.093 on Form 10-Q this morning. For more information, please refer to ARINIA's filings with 00:01:11.093 -- 00:01:15.434 the U.S. Securities and Exchange Commission and Canadian securities authorities, which 00:01:15.434 -- 00:01:19.575 are also available on A...